As the Eley Griffiths Group stock-picking competition nears its final weeks, here is a quick update of the leader-board. A confluence of events including heightened trade tensions, an oil price correction, Brexit, midterms and a general repricing of growth expectations have seen significant challenges for both developed and emerging markets.  

The Australian market has not been immune with ASX Small Ordinaries correcting 11.17%* since the day we launched the competition. The average return across the 948 entries is –20% (as at COB 12/12/2018). But that doesn’t mean there haven’t been some good performances. The Top 5 not surprisingly include a Gold stock, and a number of beaten down value names that have re-rated on significantly better news. The Bottom 5 have had stock specific issues including business closures, border standover men and poor clinical trial results.  

With 3 weeks to go and choppy markets persisting the field is still wide open.  Stay tuned for the winner announcement in January.  Good Luck  

Top 5 performers 

  1. Bellevue Gold (ASX:BGL) +81% 
  2. Paradigm Biopharmaceuticals (ASX:PAR) +50% 
  3. G8 Education (ASX:GEM) +43% 
  4. Kidman Resources (ASX:KDR) +31% 
  5. Eden Innovations (ASX:EDE) +32%


Bottom 5 performers  

  1. Freedom Insurance (ASX:FIG) -84% 
  2. Donaco (ASX:DNA) -77% 
  3. Bionomics (ASX:BNO) -75% 
  4. Althea Group (ASX: AGH) -67% 
  5. Adacel (ASX:ADA) -65%

all returns figures quotes as at COB 12/12/2018

You can find out more about the competition in this link: (VIEW LINK)

* Small Ords return taken at COB 13/12/2018